These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16170347)

  • 21. Senescence occurs with hTERT repression and limited telomere shortening in human oral keratinocytes cultured with feeder cells.
    Kang MK; Kameta A; Shin KH; Baluda MA; Park NH
    J Cell Physiol; 2004 Jun; 199(3):364-70. PubMed ID: 15095283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes.
    Fu B; Quintero J; Baker CC
    Cancer Res; 2003 Nov; 63(22):7815-24. PubMed ID: 14633708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
    Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
    Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
    Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
    Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
    Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; Sun D; Windle BE; Hurley LH; Von Hoff DD
    Cancer Res; 1999 Feb; 59(3):639-44. PubMed ID: 9973212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
    Gunaratnam M; Neidle S
    Methods Mol Biol; 2010; 613():303-13. PubMed ID: 19997892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced or diminished stabilization of the telomere G-quadruplex and inhibition of telomerase by small chemical ligands under molecular crowding condition.
    Chen Z; Zheng KW; Hao YH; Tan Z
    J Am Chem Soc; 2009 Aug; 131(30):10430-8. PubMed ID: 19588966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turning off transcription of the bcl-2 gene by stabilizing the bcl-2 promoter quadruplex with quindoline derivatives.
    Wang XD; Ou TM; Lu YJ; Li Z; Xu Z; Xi C; Tan JH; Huang SL; An LK; Li D; Gu LQ; Huang ZS
    J Med Chem; 2010 Jun; 53(11):4390-8. PubMed ID: 20481493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
    Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
    Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
    Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
    Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.
    Naasani I; Seimiya H; Tsuruo T
    Biochem Biophys Res Commun; 1998 Aug; 249(2):391-6. PubMed ID: 9712707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress.
    Matthews C; Gorenne I; Scott S; Figg N; Kirkpatrick P; Ritchie A; Goddard M; Bennett M
    Circ Res; 2006 Jul; 99(2):156-64. PubMed ID: 16794190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
    Kim JH; Kim JH; Lee GE; Kim SW; Chung IK
    Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An exonuclease I hydrolysis assay for evaluating G-quadruplex stabilization by small molecules.
    Yao Y; Wang Q; Hao YH; Tan Z
    Nucleic Acids Res; 2007; 35(9):e68. PubMed ID: 17426118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-quadruplex preferentially forms at the very 3' end of vertebrate telomeric DNA.
    Tang J; Kan ZY; Yao Y; Wang Q; Hao YH; Tan Z
    Nucleic Acids Res; 2008 Mar; 36(4):1200-8. PubMed ID: 18158301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer.
    Folini M; Pivetta C; Zagotto G; De Marco C; Palumbo M; Zaffaroni N; Sissi C
    Biochem Pharmacol; 2010 Jun; 79(12):1781-90. PubMed ID: 20206144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
    Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
    Leonetti C; Amodei S; D'Angelo C; Rizzo A; Benassi B; Antonelli A; Elli R; Stevens MF; D'Incalci M; Zupi G; Biroccio A
    Mol Pharmacol; 2004 Nov; 66(5):1138-46. PubMed ID: 15304549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
    Duan J; Chen Z; Liu P; Zhang Z; Tong T
    Int J Oncol; 2004 Jun; 24(6):1597-605. PubMed ID: 15138605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines.
    Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
    J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.